A researcher conducting a clinical nutrition trial discovers that the intervention group is experiencing mild but unexpected side effects. Stopping the study will delay results and affect funding, but continuing may put participants at risk. What is the most ethical action?

Question

Answer

Inform participants about the side effects, consult the ethics review board, and pause or adjust the study to protect participant welfare.

Answer

Reduce the dosage silently without documentation to minimize side effects and proceed as planned.

Answer

Continue the study without informing participants to avoid causing alarm and jeopardizing funding.

Answer

Complete the trial as originally designed since the side effects are mild and do not seem life-threatening.

Crowdly

A researcher conducting a clinical nutrition trial discovers that the interventi...

Want instant access to all verified answers on e-aral.center?